-+ 0.00%
-+ 0.00%
-+ 0.00%

Tenon Medical Reports Preliminary Q4 Revenue Of ~$1.45M - $1.48M, FY25 Revenue ~$3.91M To $3.94M

Benzinga·01/28/2026 13:39:59
Listen to the news

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today issued a letter to shareholders from Steve Foster, President and Chief Executive Officer.

Following record revenue growth in the third quarter, the Company is reporting preliminary, unaudited fourth quarter revenue of approximately $1.45 to $1.48 million for the period ended December 31, 2025, representing approximately 90% growth compared to the fourth quarter ended December 31, 2024. Preliminary unaudited full year 2025 revenue is expected to be approximately $3.91 to $3.94 million, representing approximately 20% year over year growth. Revenue acceleration in the second half of 2025 was driven by strong procedural volume momentum, which we expect to continue into 2026. This momentum was primarily fueled by adoption among new physician users of both the Catamaran® and SImmetry+ systems.